EUROLAB
who-stability-requirements-for-medical-oxygen-and-inhalers
Stability Studies (ICH Guidelines) BP Appendix XVI Stability of Finished Products with PreservativesBP Stability Evaluation of Modified Release PreparationsEMA CHMP/QWP/609/2014 Quality Requirements for Stability of BiosimilarsEMA CPMP/QWP/122/02 Stability Testing for Transdermal PatchesEMA Guideline for Stability of Veterinary Medicinal ProductsEMA Guideline on Holding Times for Bulk Products (Stability Implication)EMA Guideline on Stability Testing for Liposomal Drug FormulationsEMA Guideline on Stability Testing for Orally Inhaled ProductsEMA Reflection Paper on Stability for Polymers in Drug DeliveryEMA Reflection Paper on Stability of Advanced Therapies (ATMPs)EMA Stability Testing for Nanoparticle FormulationsEMA Stability Testing in Pediatric FormulationsEMA Stability Testing of Drug-Device Combination ProductsEP 1.2.1 Drug Substance Stability in Multisource SubmissionsEP 2.9.5 Uniformity of Mass Post-Stability TestingEP 3.2.1 Container Closure System Stability EvaluationEP 5.20 Climatic Conditions in Stability Storage ChambersEP 6.0 Stability Testing Requirements for MonographsEP 6.1 Real-Time Stability Testing of Biological ExtractsEP Climatic Zones IVa and IVb for ASEAN and African MarketsFDA 21 CFR 211.166 Stability Program Requirements for PharmaceuticalsFDA 21 CFR 610.17 Stability Testing of Biological ProductsFDA Accelerated Stability Protocol for Veterinary DrugsFDA cGMP Guidelines for Expiration Dating and Stability StudiesFDA Container Closure Stability Evaluation for Ophthalmic ProductsFDA Draft Guidance for Stability of Inhaled Cannabis ProductsFDA Draft Guidance on Cannabis Stability Testing in Drug DevelopmentFDA Guidance for Allergenic Products Stability AssessmentFDA Guidance for Industry: Stability Testing for Nutritional SupplementsFDA Guidance on Freeze-Thaw Stability Testing for BiologicsFDA Post-Approval Changes and Stability RequirementsFDA Q&A Guidance for Stability of Topical Dermatologic ProductsFDA Requirements for Drug Substance Holding Time & StabilityFDA Requirements for Orphan Drugs and Niche Stability StudiesICH E2E Pharmacovigilance & Stability Shelf-life ManagementICH E3 Stability Documentation in Clinical Study ReportsICH E6(R2) GCP Considerations in Clinical Trial Stability SamplesICH M10 Bioanalytical Method Validation in Stability TestingICH M4Q Stability Data Compilation for Common Technical Document (CTD)ICH M9 Stability of Biowaiver-Based Generic SubmissionsICH Q10 Pharmaceutical Quality System and Stability OversightICH Q11 Stability of Drug Substances in Developmental StagesICH Q12 Lifecycle Management and Ongoing Stability MonitoringICH Q14 Analytical Procedure Development in Stability StudiesICH Q1A(R2) Accelerated Stability Testing of Solid Oral Dosage FormsICH Q1B Photostability Testing for Light-Sensitive Drug ProductsICH Q1C Stability Testing for New Dosage Forms (Capsules, Tablets, etc.)ICH Q1D Bracketing and Matrixing Design Stability Protocol DevelopmentICH Q1E Evaluation of Stability Data for Regulatory SubmissionsICH Q1F Stability Data Requirements for Global RegistrationICH Q2(R1) Validation of Analytical Procedures in Stability StudiesICH Q3B(R2) Stability Testing of Impurities in Drug ProductsICH Q3C Residual Solvent Stability in Finished Dosage FormsICH Q4 Guidelines for Pharmacopoeial Stability HarmonizationICH Q4B Annex Stability-Related Harmonization for Global FilingICH Q5C Stability Testing of Biotechnological/Biological ProductsICH Q5D Derivation and Stability of Cell SubstratesICH Q6B Specifications Testing for Biotech Products in Long-Term StudiesICH Q8 Design Space for Stability-Critical ParametersICH Q9 Risk-Based Stability Planning and Protocol DesignICH S3B Photostability of Biologics in Animal StudiesICH S4 Stability of New Veterinary Drug Substances and ProductsICH S6(R1) Preclinical Stability of Biotech ProductsISO 10993-1 Biocompatibility Stability Studies in Medical DevicesISO 11607 Package Integrity Stability for Sterile Medical DevicesISO 13408 Stability Testing of Aseptic Processing SystemsISO 14644 Environmental Monitoring for Stability ChambersISO 14971 Risk Management Related to Stability FailuresISO 15378 GMP for Primary Packaging Stability InteractionsISO 17025 Stability Testing Accreditation RequirementsISO 17034 Reference Material Stability and HomogeneityISO 20387 Stability Assessment in Biobanking Sample StorageISO 21973 Transport Stability of Cell-Based TherapiesISO 9001:2015 Quality System Requirements for Stability ProgramsUSP <1046> Cellular and Gene Therapy Product StabilityUSP <1049> Excipient Stability and Shelf-Life EvaluationUSP <1079> Storage and Stability Testing in Distribution SystemsUSP <1086> Impurities Testing within Stability ProtocolsUSP <1090> Assessment of Drug Product Performance Post StabilityUSP <1118> Monitoring Stability in Storage and Transport ConditionsUSP <1168> Stability Testing for RadiopharmaceuticalsUSP <1191> Stability Considerations in Compounding Pharmacy ProductsUSP <1224> Transfer of Analytical Procedures in Stability StudiesUSP <1225> Validation of Compendial Procedures in Stability ContextUSP <1226> Verification of Compendial Procedures Post-StabilityUSP <671> Stability Testing of Packaging MaterialsUSP <795> Stability Evaluation of Nonsterile PreparationsUSP <797> Stability Testing of Sterile Preparations in CleanroomsWHO Annex 10 Stability Testing of Active Pharmaceutical IngredientsWHO Annex 7 Stability of Reconstituted Lyophilized ProductsWHO Annex 9 Stability for Zoonotic Biological ProductsWHO Good Storage and Distribution Practices for StabilityWHO Guidelines for Stability of DNA and mRNA VaccinesWHO Guidelines on Stability of Combination ARV TherapiesWHO Stability of Monoclonal Antibodies Under Accelerated ConditionsWHO Stability Testing for Pre-Filled Syringes and Auto-InjectorsWHO Temperature Mapping and Qualification of Stability ChambersWHO TRS 1003 Stability Protocols for Combination ProductsWHO TRS 1010 Stability Testing for Vaccines under Cold Chain ConditionsWHO TRS 1019 Stability Testing of Blood and Blood ProductsWHO TRS 953 Climatic Zone-Based Stability Testing for Global MarketsWHO TRS 970 Real-Time Stability Assessment for WHO PrequalificationWHO TRS 992 Long-Term Stability Testing for Herbal Medicinal Products

Comprehensive Guide to WHO Stability Requirements for Medical Oxygen and Inhalers Laboratory Testing Service Provided by Eurolab

The World Health Organization (WHO) has established stability requirements for medical oxygen and inhalers to ensure the quality and safety of these essential medical devices. The testing of these products is governed by a range of international standards, including ISO 80601-2-12:2011, EN 60601-2-12:2009, ASTM F2097-00, and TSE 12492:2010.

ISO Standards

The International Organization for Standardization (ISO) is responsible for developing and publishing international standards that promote global consistency and quality in products and services. ISO standards are widely adopted across the globe, and compliance with them is a critical aspect of product development and testing.

  • ISO 80601-2-12:2011 specifies the requirements for the safety and performance of medical gas supply systems for inhalation therapy.
  • ISO 80601-2-13:2011 outlines the requirements for the safety and performance of medical oxygen concentrators.
  • ISO 80601-2-14:2013 provides guidance on the testing and validation of medical oxygen equipment.
  • EN Standards

    The European Committee for Electrotechnical Standardization (CENELEC) is responsible for developing standards in Europe, which are often identical to or based on ISO standards. EN standards are widely adopted across the European Union and other countries.

  • EN 60601-2-12:2009 specifies the requirements for the safety and performance of medical gas supply systems for inhalation therapy.
  • EN 60601-2-13:2009 outlines the requirements for the safety and performance of medical oxygen concentrators.
  • ASTM Standards

    The American Society for Testing and Materials (ASTM) is responsible for developing standards in the United States. ASTM standards are widely adopted across the Americas and other countries.

  • ASTM F2097-00 specifies the requirements for the testing and validation of medical gas supply systems for inhalation therapy.
  • ASTM F2106-02 outlines the requirements for the testing and validation of medical oxygen concentrators.
  • TSE Standards

    The Turkish Standardization Institute (TSE) is responsible for developing standards in Turkey. TSE standards are widely adopted across Turkey and other countries.

  • TSE 12492:2010 specifies the requirements for the safety and performance of medical gas supply systems for inhalation therapy.
  • TSE 12493:2010 outlines the requirements for the safety and performance of medical oxygen concentrators.
  • Standard Development Organizations

    The World Trade Organization (WTO) has established a framework for international standardization, which includes the following organizations:

  • International Electrotechnical Commission (IEC)
  • International Organization for Standardization (ISO)
  • European Committee for Electrotechnical Standardization (CENELEC)
  • American Society for Testing and Materials (ASTM)
  • These organizations are responsible for developing and publishing standards that promote global consistency and quality in products and services.

    International and National Standards

    The testing of medical oxygen and inhalers is governed by a range of international and national standards, including:

  • ISO 80601-2-12:2011
  • EN 60601-2-12:2009
  • ASTM F2097-00
  • TSE 12492:2010
  • Compliance with these standards is critical to ensure the quality and safety of medical oxygen and inhalers.

    Standard Compliance Requirements

    Companies operating in the medical device industry must comply with relevant international and national standards. Failure to comply can result in regulatory penalties, product recalls, and damage to reputation.

    Standard Evolution and Updates

    Standards are regularly updated to reflect advances in technology and changes in regulations. Companies must stay up-to-date with the latest standards to ensure compliance.

    Industry-Specific Examples and Case Studies

    Companies operating in the medical device industry can benefit from case studies of successful standard implementation, such as:

  • A company that implemented ISO 80601-2-12:2011 to ensure compliance with international standards for medical gas supply systems.
  • A company that developed a new product that met ASTM F2097-00 requirements for testing and validation.
  • Additional Resources

    For more information on WHO Stability Requirements for Medical Oxygen and Inhalers, please refer to the following resources:

  • World Health Organization (WHO) website
  • International Organization for Standardization (ISO) website
  • European Committee for Electrotechnical Standardization (CENELEC) website
  • ---

    The testing of medical oxygen and inhalers is a critical aspect of product development and quality control. The WHO stability requirements for these products are essential to ensure the safety and performance of medical devices.

    Why This Test Is Needed

    The testing of medical oxygen and inhalers is necessary to:

  • Ensure compliance with international and national standards
  • Validate product performance and safety
  • Identify potential risks and defects
  • Improve product quality and reliability
  • Benefits of Standard Implementation

    Companies that implement WHO stability requirements for medical oxygen and inhalers can benefit from:

  • Reduced regulatory risk
  • Improved product quality and reliability
  • Enhanced customer satisfaction
  • Increased competitiveness
  • Common Challenges in Standard Implementation

    Companies may face challenges when implementing WHO stability requirements, such as:

  • Lack of resources and expertise
  • Limited understanding of standard requirements
  • Insufficient time and budget for testing and validation
  • Best Practices for Standard Implementation

    To overcome these challenges, companies can follow best practices, including:

  • Engaging with regulatory experts and industry stakeholders
  • Developing a comprehensive implementation plan
  • Providing training and awareness programs for employees
  • Regularly reviewing and updating standard requirements
  • Industry-Specific Examples and Case Studies

    Companies operating in the medical device industry can benefit from case studies of successful standard implementation, such as:

  • A company that implemented ISO 80601-2-12:2011 to ensure compliance with international standards for medical gas supply systems.
  • A company that developed a new product that met ASTM F2097-00 requirements for testing and validation.
  • Additional Resources

    For more information on WHO Stability Requirements for Medical Oxygen and Inhalers, please refer to the following resources:

  • World Health Organization (WHO) website
  • International Organization for Standardization (ISO) website
  • European Committee for Electrotechnical Standardization (CENELEC) website
  • ---

    Conclusion

    The testing of medical oxygen and inhalers is a critical aspect of product development and quality control. The WHO stability requirements for these products are essential to ensure the safety and performance of medical devices.

    Companies operating in the medical device industry must comply with relevant international and national standards, such as ISO 80601-2-12:2011, EN 60601-2-12:2009, ASTM F2097-00, and TSE 12492:2010. Failure to comply can result in regulatory penalties, product recalls, and damage to reputation.

    By following best practices for standard implementation, companies can ensure compliance with WHO stability requirements and improve product quality and reliability.

    ---

    Recommendations

    Based on the analysis of WHO Stability Requirements for Medical Oxygen and Inhalers, we recommend:

  • Companies operating in the medical device industry must comply with relevant international and national standards.
  • Companies must engage with regulatory experts and industry stakeholders to understand standard requirements.
  • Companies must develop a comprehensive implementation plan to ensure successful standard implementation.
  • ---

    Appendix

    For more information on WHO Stability Requirements for Medical Oxygen and Inhalers, please refer to the following resources:

  • World Health Organization (WHO) website
  • International Organization for Standardization (ISO) website
  • European Committee for Electrotechnical Standardization (CENELEC) website
  • ---

    Please let me know if you would like me to continue with the rest of the sections

    (Please respond with one of the following options)

    1. Continue with Section 2: Standard-Related Information

    2. Continue with Section 3: Why This Test Is Needed

    3. Provide feedback on the current document

    Please let me know how I can assist you further.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers